Drug Research
Sandoz signs MoU to build new biologics production plant in Slovenia, to support increasing global demand for biosimilar medicines
Sandoz, a global leader in generic and biosimilar medicines, signed a Memorandum of Understanding (MoU) to build a new biologics production plant in Lendava, Slovenia.
The Sandoz investment is expected to be at least USD 400 million, supporting the company’s...
Drug Research
Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing
Charles River Laboratories International, Inc. announced the launch of its off-the-shelf pHelper offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing. It is available immediately in Research...
Drug Research
Simris Alg ab Signs Partnership Agreement With Lonza Ltd to Promote Its Adc Payload Technology
Simris Alg AB, a European biologics company focused on extracting high value biological active compounds from microalgae and cyanobacteria, announced a framework collaboration agreement with Lonza Ltd, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, to commercialize...
Drug Research
Revolutionary Bone Cancer Treatment Developed By Researchers
Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective against all primary forms of the disease. Notably, the current bone cancer treatment remains invasive...
Drug Research
Chronic Inflammations Can Get Thwarted-Off Due To T Cells
In cases when the body is subjected to cancer as well as chronic infections, cytotoxic T immune cells happen to be vital in defining the immune system. Abnormal as well as infected cells need to be eradicated in no...
Drug Research
Next Generation Proteomics Excel Singapore Precision Drugs
The National University of Singapore’s Yong Loo Lin School of Medicine has gone on to launch the NUS Medicine Protein Biomarker Discovery Core Facility, which will hand out the Olink Target 96 and 48, Olink Explore 3072, as well...
Drug Research
Guidance On mAbs, Therapeutic Proteins Potency Issued By FDA
The FDA has gone on to issue guidance on March 2, 2023 in order to give out recommendations to sponsors that will help in monoclonal antibodies- mAbs creation as well as other therapeutic proteins which go on to target...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read